succinylacetone has been researched along with Acute Porphyria in 1 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Puy, H | 1 |
| Deybach, JC | 1 |
| Bogdan, A | 1 |
| Callebert, J | 1 |
| Baumgartner, M | 1 |
| Voisin, P | 1 |
| Nordmann, Y | 1 |
| Touitou, Y | 1 |
1 other study available for succinylacetone and Acute Porphyria
| Article | Year |
|---|---|
Increased delta aminolevulinic acid and decreased pineal melatonin production. A common event in acute porphyria studies in the rat.
Topics: Acetylserotonin O-Methyltransferase; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminolevul | 1996 |